Dow Jones

39,127.80

0.04%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
First Wave BioPharma Inc (FWBI)
First Wave BioPharma Inc (FWBI) Noticias

FWBI

First Wave BioPharma (FWBI)

First Wave BioPharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FWBI

1 2 3 4 5 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
24/06/2024	07:03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FWBI	First Wave BioPharma Inc
20/06/2024	15:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FWBI	First Wave BioPharma Inc
17/06/2024	16:23	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:FWBI	First Wave BioPharma Inc
14/06/2024	16:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:FWBI	First Wave BioPharma Inc
10/06/2024	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:FWBI	First Wave BioPharma Inc
31/05/2024	16:25	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FWBI	First Wave BioPharma Inc
30/05/2024	16:32	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:FWBI	First Wave BioPharma Inc
30/05/2024	16:18	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:FWBI	First Wave BioPharma Inc
16/05/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma Changes Name to Entero Therapeutics	NASDAQ:FWBI	First Wave BioPharma Inc
14/05/2024	16:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FWBI	First Wave BioPharma Inc
13/05/2024	15:59	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:FWBI	First Wave BioPharma Inc
10/05/2024	06:55	GlobeNewswire Inc.	First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market	NASDAQ:FWBI	First Wave BioPharma Inc
09/05/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month	NASDAQ:FWBI	First Wave BioPharma Inc
24/04/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients	NASDAQ:FWBI	First Wave BioPharma Inc
17/04/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase	NASDAQ:FWBI	First Wave BioPharma Inc
15/04/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference	NASDAQ:FWBI	First Wave BioPharma Inc
18/03/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference	NASDAQ:FWBI	First Wave BioPharma Inc
14/03/2024	05:00	GlobeNewswire Inc.	First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline	NASDAQ:FWBI	First Wave BioPharma Inc
05/03/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference	NASDAQ:FWBI	First Wave BioPharma Inc
04/03/2024	07:00	GlobeNewswire Inc.	First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering	NASDAQ:FWBI	First Wave BioPharma Inc
13/02/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024	NASDAQ:FWBI	First Wave BioPharma Inc
23/01/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma to Present at the DealFlow MicroCap Conference	NASDAQ:FWBI	First Wave BioPharma Inc
17/01/2024	15:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FWBI	First Wave BioPharma Inc
17/01/2024	06:00	GlobeNewswire Inc.	First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico	NASDAQ:FWBI	First Wave BioPharma Inc
04/01/2024	05:00	GlobeNewswire Inc.	First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024	NASDAQ:FWBI	First Wave BioPharma Inc
28/12/2023	11:21	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:FWBI	First Wave BioPharma Inc
27/12/2023	10:55	GlobeNewswire Inc.	First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced	NASDAQ:FWBI	First Wave BioPharma Inc
27/12/2023	07:04	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:FWBI	First Wave BioPharma Inc
27/12/2023	05:00	GlobeNewswire Inc.	First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program	NASDAQ:FWBI	First Wave BioPharma Inc
18/12/2023	05:00	GlobeNewswire Inc.	First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company	NASDAQ:FWBI	First Wave BioPharma Inc